Alnylam Pharmaceuticals reported $-212927000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -84M 3M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Moderna Inc MRNA:US 3.55B 489M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NVS:US $ 4544M 120M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Regulus Therapeutics RGLS:US $ -8.63M 2.6M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Takeda 4502:JP Y 61447M 161531M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
Xencor XNCR:US $ -40.19M 92.44M